Chemopreventive treatment with cetuximab delays HNSCC onset in Tgfbr1/Pten 2cKO mice and reduced HIF-1α- and Notch1-mediated angiogenesis. This evidence concerns the gene PTEN and head and neck squamous cell carcinoma.